泰坦製藥 TTNP 深 滬
已收盤 10-01 16:00:00 美东时间
4.61
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 4.61
- 總市值 613.22万
- 52周最高 5.76
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 3.03
- 委 比 0.00%
- 總股本 133.02万
- 歷史最高 36000.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 3.03
- 每 手 1
- 風險率 0.46%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Titan Pharmaceuticals, Inc. Announces Closing of Merger with Black Titan Corporation
Titan Pharmaceuticals, Inc. completed its merger with Black Titan Corporation and TalenTec Sdn. Bhd. The combined company will trade as BTTC on Nasdaq. Titan became a wholly owned subsidiary of Black Titan on Oct. 1, 2025, with its shares converted into Black Titan's shares at a 1:1 ratio. Trading of Titan's stock ceased on Oct. 1, and Black Titan's shares began trading on Oct. 2. CEO Chay W. J. emphasized a new chapter of innovation and global e...
2025-10-03 21:26
Titan Pharmaceuticals Undergoes Leadership Restructuring
An update from Titan Pharmaceuticals ( ($TTNP) ) is now available. On October 1...
2025-10-02 04:51
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Check-Cap (NASDAQ:CHEK) stock rose 25.5% to $2.66 during Monday's afte...
2025-09-16 05:06
Titan Pharmaceuticals Approves Merger with Black Titan
Titan Pharmaceuticals ( ($TTNP) ) just unveiled an update. On August 26, 2025, ...
2025-08-27 04:32
Titan Pharmaceuticals Announces Merger with Black Titan
New activity is brewing for Titan Pharmaceuticals ( ($TTNP) ). The company has ...
2025-07-23 05:33
Titan Pharmaceuticals Completes Securities Purchase Agreement
Titan Pharmaceuticals ( ($TTNP) ) just unveiled an update. On June 24, 2025, Ti...
2025-06-28 04:59
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
Titan Pharmaceuticals announced the completion of a private placement of 60,000 shares of its Series C Convertible Preferred Stock to Blue Harbour Asset Management for $600,000 at a conversion price of $3.40. The transaction includes a beneficial ownership blocker limiting Blue Harbour to a maximum of 19.99% of the Company's outstanding common stock. The shares were sold under Regulation S and are subject to a registration rights agreement. Addit...
2025-06-27 20:05
Titan Pharmaceuticals Announces Filing By Black Titan Corporation With SEC For Previously Announced Proposed Combination Of Titan And TalenTec
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) ("Titan" or the "Company") announced today the filing by Black Titan Corporation with the U.S. Securities and Exchange Commission ("SEC") of a registration statement on Form F-4
2025-06-03 20:49
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
Titan Pharmaceuticals and TalenTec have entered into a Merger Agreement for a "reverse merger" transaction. Black Titan Corporation filed a Form F-4 with the SEC, including a preliminary proxy statement, in connection with the proposed combination. The transaction requires approval from Titan's stockholders and is expected to close in the third quarter of 2025, subject to customary closing conditions. Investors are advised to review the prelimina...
2025-06-03 12:45
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) stock moved upwards by 63.1% to $...
2025-04-23 05:05
